| Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
|---|---|---|---|---|---|---|
| Vifa3g05034 | ATGTTTAATCTCTGGGGGAGTTCTCAACAAGATCAACAGACCAAAGATGCTCAAGCTGAATCCAAGATAAATGAGCTCAAGGTTGCAATTGGACCTTTATCAGGAAACAAATTGAAGTACTGCAATGATGCTTGTTTGAGGCGATACCTAGACGCTCGCAACTGGAATGTTGACAAGTCGAAAAAGATGTTGGAAGACACACTTAAGTGGAGATCAGTCTATAAGCCCGAGAAAATCCGCTGGGACGAGGTTGCAGAGGAAGGGGAGACAGGGAAAGTTTATAGAGCGGGTTTTCATGACAGACATGGAAGAACTGTTCTTATTTTGAGACCTGGAATGCAGAACACTTCTTCATTGGACAATCAGATTAAGCATCTTGTGTATCTTTTGGAAAATGCTATGCTTAATCTTCCACCAGGTCAAGAACAAATGGCTTGGTTGATAGACTTCACTGGGTGGTCAATAACCAACAACGTGCCACTCAAATCCGCTAGAGAGACTATCAGTATTCTACAGAATCACTATCCTGAGAGGCTTGGAATAGCTTTTCTTTATAACCCTCCTCGAATTTTCGAAGCTTTTTGGAAGATAGTGAAGTATTTCTTGGATAGCAAGACATTTCAGAAGGTGAAATTTGTGTATCCGAAGAATAAAGATAGCGTGGAGCTCATGAAATCTTATTTTGATGAGGAAAATCTTCCAAGTGAACTAGACTTTTGGGGTTCTGAAGAAAAACTCTCAAACCACATGCATTGTGCAGCAGAAGTTGCTCCAGAAGTTGCTATCTGA | 789 | 0.4094 | MFNLWGSSQQDQQTKDAQAESKINELKVAIGPLSGNKLKYCNDACLRRYLDARNWNVDKSKKMLEDTLKWRSVYKPEKIRWDEVAEEGETGKVYRAGFHDRHGRTVLILRPGMQNTSSLDNQIKHLVYLLENAMLNLPPGQEQMAWLIDFTGWSITNNVPLKSARETISILQNHYPERLGIAFLYNPPRIFEAFWKIVKYFLDSKTFQKVKFVYPKNKDSVELMKSYFDEENLPSELDFWGSEEKLSNHMHCAAEVAPEVAI | 262 |
| Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
|---|---|---|---|---|---|---|---|---|
| Vifa3g05034 | 262 | SUPERFAMILY | CRAL/TRIO domain | 81 | 237 | IPR036865 | - | |
| Vifa3g05034 | 262 | ProSiteProfiles | CRAL-TRIO lipid binding domain profile. | 81 | 237 | IPR001251 | - | |
| Vifa3g05034 | 262 | SMART | sec14_4 | 87 | 245 | IPR001251 | - | |
| Vifa3g05034 | 262 | SMART | CRAL_TRIO_N_2 | 42 | 67 | IPR011074 | - | |
| Vifa3g05034 | 262 | Gene3D | - | 5 | 256 | IPR036865 | - | |
| Vifa3g05034 | 262 | Pfam | CRAL/TRIO, N-terminal domain | 42 | 66 | IPR011074 | - | |
| Vifa3g05034 | 262 | FunFam | Phosphatidylinositol transfer protein 3 | 3 | 257 | - | - | |
| Vifa3g05034 | 262 | PANTHER | GH16843P | 10 | 237 | - | - | |
| Vifa3g05034 | 262 | Pfam | CRAL/TRIO domain | 89 | 237 | IPR001251 | - | |
| Vifa3g05034 | 262 | SUPERFAMILY | CRAL/TRIO N-terminal domain | 15 | 83 | IPR036273 | - | |
| Vifa3g05034 | 262 | CDD | SEC14 | 89 | 237 | IPR001251 | - |
| Select | Gene | Chromosome | Start | End | Duplicated_type |
|---|---|---|---|---|---|
| Vifa3g05034 | Vifa-Chr3 | 1466910776 | 1466912929 | Dispersed/Wgd |
| Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
|---|---|---|---|---|---|---|---|---|
| Vifa3g05034 | 46 | 248 | Acyl Lipid Metabolism Gene Families | AT1G55840 | 27.753 | 4.04e-11 | 60.5 |
| Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
|---|---|---|---|---|---|---|
| Vifa3g05034 | K26544 | - | gmx:100800854 | 416.772 |
| Select | Gene_1 | Chr_1 | Start_1 | End_1 | Gene_2 | Chr_2 | Start_2 | End_2 | Event_name |
|---|---|---|---|---|---|---|---|---|---|
| Vifa3g05034 | 3 | 1466910776 | 1466912929 | Vifa3g05034 | 3 | 1466910776 | 1466912929 | ECH |